Zhao CY - Search Results

1

Conversion therapy in advanced perihilar cholangiocarcinoma based on patient-derived organoids: A case report.

He YG, Zhang LY, Li J, Wang Z, Zhao CY, Zheng L, Huang XB. He YG, et al. Among authors: zhao cy. World J Gastrointest Oncol. 2024 Oct 15;16(10):4274-4280. doi: 10.4251/wjgo.v16.i10.4274. World J Gastrointest Oncol. 2024. PMID: 39473955 Free PMC article.

2

Evaluation of Preoperative Inflammation-Based Prognostic Scores in Patients With Intrahepatic Cholangiocarcinoma: A Multicenter Cohort Study.

He C, Zhao C, Lu J, Huang X, Chen C, Lin X. He C, et al. Front Oncol. 2021 Jun 17;11:672607. doi: 10.3389/fonc.2021.672607. eCollection 2021. Front Oncol. 2021. PMID: 34221991 Free PMC article.

3

Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts.

Zhao C, He C, Lu J, Huang X, Chen C, Lin X. Zhao C, et al. Front Oncol. 2022 Apr 8;12:832038. doi: 10.3389/fonc.2022.832038. eCollection 2022. Front Oncol. 2022. PMID: 35463346 Free PMC article.

4

The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis.

Huang G, Xi P, Yao Z, Zhao C, Li X, Chen Z, Lin X. Huang G, et al. J Inflamm Res. 2024 May 7;17:2787-2799. doi: 10.2147/JIR.S460103. eCollection 2024. J Inflamm Res. 2024. PMID: 38737115 Free PMC article.

5

The conditional recurrence-free survival after R0 hepatectomy for locally advanced intrahepatic cholangiocarcinoma: A competing risk analysis based on inflammation-nutritional status.

Huang G, Xi P, Yao Z, Zhao C, Li X, Lin X. Huang G, et al. Heliyon. 2024 Jul 2;10(13):e33931. doi: 10.1016/j.heliyon.2024.e33931. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39055818 Free PMC article.

6

Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma.

Cai Z, He C, Zhao C, Lin X. Cai Z, et al. Front Oncol. 2021 Apr 1;11:611118. doi: 10.3389/fonc.2021.611118. eCollection 2021. Front Oncol. 2021. PMID: 33868997 Free PMC article.

7

Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma.

Zhao C, Li X, Luo L, Chen C, He C. Zhao C, et al. Cancer Cell Int. 2023 Jul 29;23(1):148. doi: 10.1186/s12935-023-03005-6. Cancer Cell Int. 2023. PMID: 37516863 Free PMC article.

8

Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection.

Li XH, Zhou EL, Zhao CY, Cui BK, Dong XY, Du H, Lin XJ. Li XH, et al. Among authors: zhao cy. Cancer Med. 2023 Dec;12(24):21742-21750. doi: 10.1002/cam4.6738. Epub 2023 Dec 7. Cancer Med. 2023. PMID: 38059559 Free PMC article.

9

Adjuvant chemotherapy in pancreatic cancer at different AJCC stages: a propensity score matching analysis.

Li XH, Zhou EL, Dong XY, Zhao CY, Han YX, Cui BK, Lin XJ. Li XH, et al. Among authors: zhao cy. Eur J Med Res. 2023 Dec 19;28(1):606. doi: 10.1186/s40001-023-01572-y. Eur J Med Res. 2023. PMID: 38115156 Free PMC article.

10

Low HOXC10 expression in liver cancer regulates proliferation via a mechanism involving miR-221 and the MAPK signaling pathway.

Ma K, Zhao C, Guo K, Fu Z, Che C, Dong B, Pang C, Zhang S, Liu W, Yang Z, Liang R, Wang L. Ma K, et al. Oncol Lett. 2020 Nov;20(5):127. doi: 10.3892/ol.2020.11988. Epub 2020 Aug 19. Oncol Lett. 2020. PMID: 32934696 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

494 results

Search Page

Filters